Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium ...( PURCHASE N.Y. Sept. 11 /- Nutriti...),Health

PURCHASE, N.Y., Sept. 11 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI), the developer and marketer of nutritional supplements under the Iceland Health Chromax(R), and Diabetes Essentials(TM) brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and reduce chronic joint pain, reported today that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements. Results of the studies can be viewed at the NTP website at: http://ntp.niehs.nih.gov/?objectid=BD466797-123F-7908-7B4627379E1CE3E6.

Michael A. Zeher, president and chief executive officer of Nutrition 21, commented, "We are pleased with the conclusions of the NTP studies. Over the years Chromax chromium picolinate has proven to be an efficacious compound in assisting consumers to safely and proactively attain, and maintain, healthy blood glucose levels, carbohydrate metabolism, and body composition. Chromax chromium picolinate is used as a nutritional ingredient in a wide variety of dietary supplements and functional food and beverage products from leading manufacturing companies. The results of these highly credible studies build upon the extensive database of safety data behind our products, and help provide retailers and consumers with the added confidence they need to initially buy our product and to become loyal repeat customers."

"The results from th
'/>"/>